Sunspotter, for years your central thesis about CTIX then IPIX was that you were here to warn all of us retail investors that this was a garden variety OTC penny stock scam. Have you changed your position on IPIX now that you are commenting on clinical trials? If so, welcome.
The likely protocol is to add Brilacidin to Remdesivir as treatment. It would be unethical have an unproven drug go against any standard of care along with a placebo group. Brilacidin has tested as a combination with Remdesivir, so the grouping would be Remdesivir plus B and Remdesivir plus placebo. The R + B group would then have an escalation for only B to find optimization. The outcomes would then look for increased efficacy over R alone. Remdesivir has such a low benefit over no treatment that increased benefit is a very low bar.